Skip to main content
. Author manuscript; available in PMC: 2014 Sep 23.
Published in final edited form as: Cochrane Database Syst Rev. 2003;(3):CD003252. doi: 10.1002/14651858.CD003252

Comparison 1.

Second trimester amniocentesis versus control

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Not complied with allocated procedure 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 1.73 [1.03, 2.91]
3 Multiple insertions 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 91.08 [5.61, 1477. 53]
4 Second test performed 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 41.04 [2.48, 678.07]
5 Laboratory failure 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 27.02 [1.61, 454.31]
6 All non-mosaic abnormalities 1 4593 Risk Ratio (M-H, Fixed, 95% CI) 30.85 [1.85, 515.31]
13 Vaginal bleeding after test 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.66, 1.37]
14 Amniotic leakage after test 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 3.90 [1.95, 7.80]
20 All known pregnancy loss (including termination of pregnancy) 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 1.41 [0.99, 2.00]
21 Termination of pregnancy (all) 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 2.50 [0.97, 6.44]
24 Spontaneous miscarriage 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 1.60 [1.02, 2.52]
26 Perinatal deaths 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 0.63 [0.28, 1.38]
27 Stillbirths 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.36, 1.93]
28 Neonatal deaths 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 0.11 [0.01, 2.06]
29 All recorded deaths after viability 1 4606 Risk Ratio (M-H, Fixed, 95% CI) 0.63 [0.28, 1.38]
30 Anomalies (all recorded) 1 4507 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.62, 1.39]
31 Talipes 1 4507 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.37, 1.22]
35 Neonatal respiratory distress syndrome 1 4507 Risk Ratio (M-H, Fixed, 95% CI) 2.11 [1.06, 4.19]